GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Dividend Payout Ratio

BioPharma Credit (LSE:BPCR) Dividend Payout Ratio : 0.91 (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. BioPharma Credit's Dividend Payout Ratio for the months ended in Jun. 2024 was 0.91.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of BioPharma Credit PLC is 1.01, which seems too high.

The historical rank and industry rank for BioPharma Credit's Dividend Payout Ratio or its related term are showing as below:

LSE:BPCR' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.52   Med: 0.83   Max: 1.13
Current: 1.01


During the past 7 years, the highest Dividend Payout Ratio of BioPharma Credit was 1.13. The lowest was 0.52. And the median was 0.83.

LSE:BPCR's Dividend Payout Ratio is ranked worse than
75.8% of 1037 companies
in the Asset Management industry
Industry Median: 0.57 vs LSE:BPCR: 1.01

As of today (2025-03-02), the Dividend Yield % of BioPharma Credit is 8.06%.

During the past 7 years, the highest Trailing Annual Dividend Yield of BioPharma Credit was 8.58%. The lowest was 5.42%. And the median was 7.25%.

BioPharma Credit's Dividends per Share for the months ended in Jun. 2024 was $0.05.

During the past 12 months, BioPharma Credit's average Dividends Per Share Growth Rate was 25.70% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 2.70% per year.

During the past 7 years, the highest 3-Year average Dividends Per Share Growth Rate of BioPharma Credit was 6.50% per year. The lowest was 6.50% per year. And the median was 6.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


BioPharma Credit Dividend Payout Ratio Historical Data

The historical data trend for BioPharma Credit's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit Dividend Payout Ratio Chart

BioPharma Credit Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial 0.79 1.08 1.13 0.52 0.84

BioPharma Credit Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.42 0.65 1.21 0.91

Competitive Comparison of BioPharma Credit's Dividend Payout Ratio

For the Asset Management subindustry, BioPharma Credit's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioPharma Credit's Dividend Payout Ratio Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BioPharma Credit's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where BioPharma Credit's Dividend Payout Ratio falls into.



BioPharma Credit Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

BioPharma Credit's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0.07/ 0.083
=0.84

BioPharma Credit's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0.053/ 0.058
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioPharma Credit (LSE:BPCR) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


BioPharma Credit Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioPharma Credit Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit Headlines

No Headlines